Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer

BACKGROUND: Colon cancer remains one of the most common malignancies across the world. Thus far, a biomarker, which can comprehensively predict the survival outcomes, clinical characteristics, and therapeutic sensitivity, is still lacking. METHODS: We leveraged transcriptomic data of colon cancer fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yonggan, Ning, Bobin, Liu, Hongyi, Jia, Baoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928673/
https://www.ncbi.nlm.nih.gov/pubmed/35300596
http://dx.doi.org/10.1186/s12876-022-02200-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928673/
https://www.ncbi.nlm.nih.gov/pubmed/35300596
http://dx.doi.org/10.1186/s12876-022-02200-5

Ejemplares similares